Support for Drug Developers in Planning for Post-Approval & Commercialization
Fluence partners with drug developers to plan for the successful rollout and integration of psychedelic treatments in real-world clinical and community-based settings.
With expertise in evidence-based training and education, we offer comprehensive support for ongoing clinician development, clinic staff training, and patient education that meet medical, legal, and regulatory compliance standards. The flexibility of our program design helps organizations scale their offerings while ensuring ethical, high-quality care.
We offer initial and ongoing education for clinicians working with your drug products, ensuring they are equipped to deliver high-quality care in direct care settings. This training supports:
Therapeutic best practices aligned to the indication and REMS strategy
Competency development for new clinicians entering the field
Continuous education to maintain treatment fidelity and clinical excellence
Beyond mental health clinicians, we provide specialized training for clinic staff to ensure smooth operational workflows. Training includes:
Preparation and support for patient interactions
Protocol adherence and compliance with safety regulations
Care coordination strategies for multidisciplinary teams
We develop and deliver customized, patient education resources aligned to therapy protocols and clinical contexts. These materials support:
Informed patient participation in psychedelic therapies
Guidance for caregivers and other social supports
Educational supports for post-treatment integration
While drug developers cannot promote off-label uses, Fluence offers independent, evidence-informed training programs for clinicians exploring emerging therapeutic applications.
Our programs ensure that these practices are grounded in scientific research and ethical frameworks, empowering clinicians to safely and responsibly expand access to innovative treatments.
01
Ensure quality control in treatment delivery across diverse clinical settings
02
Optimize safety & efficacy of psychedelic-assisted therapies
03
Access our growing community of talented, dedicated clinicians
04
Improve patient outcomes through effective training and education programs
Consultation for
Drug Development
AI for
Clinical Trial Training
For more information about Fluence’s innovative training programs and partnerships, contact us.
